Skip to main content
. Author manuscript; available in PMC: 2021 May 6.
Published in final edited form as: Vaccine. 2020 Apr 8;38(21):3699–3701. doi: 10.1016/j.vaccine.2020.03.038

Table 1.

Reasons primary care physicians are or are not in favor of harmonization across genders of the recommended catch-up HPV vaccination age for everyone through age 26 years, by physician specialty — United States, 2018.

Total N* (%) Pediatrics n(%) Family Medicine n(%) Internal Medicine n(%)
If you are IN FAVOR of the change to harmonize the recommended age, why? 724 (100) 294 (100) 232 (100) 198 (100)
 Simplify the vaccination schedule** 709 (97.9) 284 (96.6) 231 (99.6) 194 (98.0)
 Easier to implement** 684 (94.5) 270 (91.8) 225 (97.0) 189 (95.5)
 Easier to explain to patients 679 (93.8) 270 (91.8) 219 (94.4) 190 (96.0)
 Facilitate reaching high-risk populations 619 (85.5) 256 (87.1) 195 (84.1) 168 (84.9)
 Reduce burden on health care providers 558 (77.1) 224 (76.2) 187 (80.6) 147 (74.2)
 Create equity between genders** 420 (58.0) 199 (67.7) 122 (52.6) 99 (50.0)
If you are NOT IN FAVOR of the change to harmonize the recommended age, why not? 52 (100) 13 (100) 17 (100) 22 (100)
 I don’t have a problem with the current recommendation 46 (88.5) 12 (92.3) 15 (88.2) 19 (86.4)
 Vaccination is less cost-effective in older age groups 26 (50.0) 7 (53.9) 9 (52.9) 10 (45.5)
 I don’t think HPV vaccine should be administered to all males over age 21 years** 24 (46.2) 2 (15.4) 12 (70.6) 10 (45.5)
*

Missing 35/820 (4.3%) who did not answer whether or not they favored the change, 6/730 (0.8%) who did not state any reasons why they were in favor of the change, and 3/55 (5.5%) who did not state any reasons why they were not in favor of the change.

**

p < 0.05 for difference between specialties.